Frontiers in Cardiovascular Medicine (May 2024)

Inflammation and coronary microvascular disease: relationship, mechanism and treatment

  • Zehui Guo,
  • Zehui Guo,
  • Zehui Guo,
  • Zhihua Yang,
  • Zhihua Yang,
  • Zhihui Song,
  • Zhihui Song,
  • Zhenzhen Li,
  • Zhenzhen Li,
  • Yang Xiao,
  • Yuhang Zhang,
  • Yuhang Zhang,
  • Tao Wen,
  • Tao Wen,
  • Guiyun Pan,
  • Guiyun Pan,
  • Haowei Xu,
  • Haowei Xu,
  • Xiaodi Sheng,
  • Xiaodi Sheng,
  • Guowang Jiang,
  • Guowang Jiang,
  • Liping Guo,
  • Yi Wang,
  • Yi Wang

DOI
https://doi.org/10.3389/fcvm.2024.1280734
Journal volume & issue
Vol. 11

Abstract

Read online

Coronary microvascular disease (CMVD) is common in patients with cardiovascular risk factors and is linked to an elevated risk of adverse cardiovascular events. Although modern medicine has made significant strides in researching CMVD, we still lack a comprehensive understanding of its pathophysiological mechanisms due to its complex and somewhat cryptic etiology. This greatly impedes the clinical diagnosis and treatment of CMVD. The primary pathological mechanisms of CMVD are structural abnormalities and/or dysfunction of coronary microvascular endothelial cells. The development of CMVD may also involve a variety of inflammatory factors through the endothelial cell injury pathway. This paper first reviews the correlation between the inflammatory response and CMVD, then summarizes the possible mechanisms of inflammatory response in CMVD, and finally categorizes the drugs used to treat CMVD based on their effect on the inflammatory response. We hope that this paper draws attention to CMVD and provides novel ideas for potential therapeutic strategies based on the inflammatory response.

Keywords